Vascular hemichorea/hemiballism and topiramate

Movement Disorders

Volumn 19, Issue 7, 2004, Pages 836-838

  Gatto, Emilia Mabel ^a,b   Roca, Claudia Uribe ^a   Raina, Gabriela ^a   Gorja, Marcelo ^a   Folgar, Silvia ^a   Micheli, Federico E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

Hemiballism; Hemichorea; Topiramate

Indexed keywords

CLONAZEPAM; HALOPERIDOL; OLANZAPINE; TOPIRAMATE;

AGED; ANXIETY DISORDER; ARTICLE; CAROTID ENDARTERECTOMY; CASE REPORT; CEREBROVASCULAR DISEASE; CHOREA; CLINICAL FEATURE; DISEASE EXACERBATION; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG RESPONSE; HEMIBALLISM; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; IRRITABILITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; TIC; TREATMENT OUTCOME;

AGED; ANTICONVULSANTS; BASAL GANGLIA; CEREBROVASCULAR ACCIDENT; CHOREA; DYSKINESIAS; FRUCTOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 4344649101     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20086     Document Type: Article

References (17)

1. Lang AL. Movement disorder symptomatology. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. Boston: Butterworth-Heinemann; 1996. p 299-320.
2. Kase CS, Maulsby GO, De Juan E, Mohr JP. Hemichorea-hemiballism and lacunar infarction in the basal ganglia. Neurology 1981;31:452-455.
3. Dewey RB, Jankovich J. Hemiballism-hemichorea: clinical and pharmacological findings in 21 patients. Arch Neurol 1989;46: 862-867.
4. Johnson WG, Fahn S. Treatment of vascular hemiballism and hemichorea. Neurology 1977;27:634-636.
5. Sethi KD, Patel BP. Inconsistent response to divalproex sodium in hemichorea/hemiballism. Neurology 1990;40:1630-1631.
6. Kothare SV, Pollack P, Kulberg AG, Ravin PD. Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus. Pediatr Neurol 2000;22:68-71.
7. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000;41(Suppl. 1):S3-S9.
8. Piccolo I, Defanti CA, Soliveri P, Volonté MA, Cislaghi G, Girotti F. Cause and course in a series of patients with sporadic chorea. J Neurol 2003;250:429-435.
9. Galian R, Juni J, Castillo A, Parra J, Peiro C, Sancho J. Vascular hemichorea: clinical-radiological correlation. Rev Neurol 2000;30: 409-411.
10. Hashimoto T, Morita H, Tada T, Maruyama T, Yamada Y, Ikeda S. Neuronal activity in the globus pallidus in chorea caused by striatal lacunar infarction. Ann Neurol 2001;50:528-531.
11. De Long MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;40:281-285.
12. Kim JS, Lee KS, Kim YI, Kim BS, Chung YA, Chung SK. Evidence of thalamic disinhibition in patients with hemichorea: semiquantitative analysis using SPECT. J Neurol Neurosurg Psychiatry 2002;72:329-333.
13. Pantano P, DiCesare S, Ricci M, Gualdi GF, Sabatini U, Di Piero V. Hemichorea after a striatal ischemic lesion: evidence of thalamic disinhibition using a single-photon emission computed tomography: a case report. Mov Disord 1996;11:444-447.
14. Connor GS. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology 2002;59:132-134.
15. Connor GS. Topiramate as a novel treatment for essential tremor. Mov Disord 1999;14:908.
16. Ghika-Schmid F, Ghika J, Regli F, Bogousslavsky J. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry. J Neurol Sci 1997;146:109-116.
17. Glauser TA. Topiramate. Epilepsia 1999;40:985-991.